Pharmaceutical Innovations in Brain Ischemia Market
Pharmaceuticals remain at the forefront of treatment in the Brain Ischemia Market. Thrombolytic drugs like tissue plasminogen activator (tPA) help dissolve blood clots and restore cerebral blood flow. Additionally, anticoagulants and antiplatelet medications prevent clot formation, reducing stroke recurrence risk. Research is ongoing to develop neuroprotective agents that minimize brain damage during ischemia. Despite challenges like limited therapeutic windows and side effects, pharmaceutical advancements continue to improve patient outcomes and expand treatment options.
12 Views